PepGen Inc. (PEPG)
4.36
-0.68
(-13.49%)
USD |
NASDAQ |
Nov 13, 16:00
4.30
-0.06
(-1.38%)
Pre-Market: 09:19
PepGen Net Income (Quarterly) : -19.39M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -19.39M |
| June 30, 2026 | -17.81M |
| March 31, 2026 | -17.76M |
| December 31, 2025 | -18.34M |
| September 30, 2025 | -18.03M |
| June 30, 2025 | -23.09M |
| March 31, 2025 | -30.20M |
| December 31, 2024 | -22.24M |
| September 30, 2024 | -21.38M |
| June 30, 2024 | -28.34M |
| March 31, 2024 | -18.02M |
| December 31, 2023 | -19.50M |
| Date | Value |
|---|---|
| September 30, 2023 | -23.29M |
| June 30, 2023 | -19.52M |
| March 31, 2023 | -16.32M |
| December 31, 2022 | -14.94M |
| September 30, 2022 | -18.61M |
| June 30, 2022 | -17.32M |
| March 31, 2022 | -18.25M |
| December 31, 2021 | -7.144M |
| September 30, 2021 | -8.112M |
| March 31, 2021 | -6.636M |
| December 31, 2020 | -0.797M |
| September 30, 2020 | -0.337M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -46.42M |
| IRulya Therapeutics, Inc. | -27.74M |
| Q32 Bio, Inc. | -8.922M |
| Bridgebio Oncology Therapeutics, Inc. | -34.18M |
| Oncolytics Biotech, Inc. | -9.705M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 19.39M |
| EPS Diluted (Quarterly) | -0.28 |
| Enterprise Value | 212.78M |
| Earnings Yield | -24.34% |
| Normalized Earnings Yield | -24.34 |